Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myofibroblasts | 6 | 2020 | 204 | 3.130 |
Why?
|
| Cyclooxygenase 2 | 6 | 2020 | 630 | 2.310 |
Why?
|
| Protein Kinase C | 8 | 2020 | 1268 | 1.890 |
Why?
|
| Ribonuclease, Pancreatic | 2 | 2023 | 155 | 1.620 |
Why?
|
| Colon | 8 | 2020 | 1758 | 1.590 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2023 | 4449 | 1.310 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2016 | 61 | 1.190 |
Why?
|
| Bradykinin | 3 | 2020 | 221 | 1.140 |
Why?
|
| Personnel Selection | 1 | 2020 | 197 | 0.670 |
Why?
|
| Cultural Diversity | 1 | 2020 | 346 | 0.610 |
Why?
|
| Colitis | 1 | 2023 | 1137 | 0.540 |
Why?
|
| Colonic Polyps | 1 | 2018 | 518 | 0.500 |
Why?
|
| Cell Movement | 2 | 2016 | 5387 | 0.490 |
Why?
|
| Colectomy | 1 | 2018 | 650 | 0.490 |
Why?
|
| Minority Groups | 1 | 2020 | 1088 | 0.470 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 150 | 0.450 |
Why?
|
| Abdominal Abscess | 1 | 2013 | 145 | 0.440 |
Why?
|
| Diverticulitis, Colonic | 1 | 2013 | 123 | 0.440 |
Why?
|
| Diverticulitis | 1 | 2014 | 169 | 0.430 |
Why?
|
| Cell Communication | 1 | 2019 | 1633 | 0.430 |
Why?
|
| Intestinal Perforation | 1 | 2013 | 256 | 0.420 |
Why?
|
| Colonoscopy | 2 | 2018 | 1311 | 0.420 |
Why?
|
| Lactones | 2 | 2003 | 337 | 0.380 |
Why?
|
| Lysophospholipids | 1 | 2011 | 328 | 0.340 |
Why?
|
| Students, Medical | 1 | 2020 | 1768 | 0.320 |
Why?
|
| Laparoscopy | 1 | 2018 | 1980 | 0.310 |
Why?
|
| Treatment Refusal | 2 | 2020 | 420 | 0.300 |
Why?
|
| Colorectal Neoplasms | 3 | 2021 | 6588 | 0.280 |
Why?
|
| Lung Transplantation | 1 | 2014 | 1163 | 0.270 |
Why?
|
| Phosphorylation | 6 | 2020 | 8647 | 0.260 |
Why?
|
| Rectal Neoplasms | 2 | 2021 | 1120 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 4 | 2023 | 22636 | 0.200 |
Why?
|
| Intestinal Mucosa | 4 | 2015 | 3032 | 0.200 |
Why?
|
| Job Application | 1 | 2020 | 40 | 0.200 |
Why?
|
| Internship and Residency | 1 | 2020 | 5623 | 0.190 |
Why?
|
| Tight Junctions | 1 | 2003 | 325 | 0.190 |
Why?
|
| Duodenal Neoplasms | 1 | 2020 | 107 | 0.190 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 18175 | 0.190 |
Why?
|
| Up-Regulation | 2 | 2012 | 4303 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2009 | 4223 | 0.170 |
Why?
|
| Hyperthermia, Induced | 1 | 2021 | 366 | 0.170 |
Why?
|
| Anus Neoplasms | 1 | 2021 | 295 | 0.160 |
Why?
|
| Cell Line | 5 | 2016 | 16559 | 0.160 |
Why?
|
| Epithelial Cells | 4 | 2005 | 3630 | 0.160 |
Why?
|
| Interleukin-10 | 1 | 2023 | 1205 | 0.160 |
Why?
|
| Protein Kinase C-epsilon | 4 | 2005 | 49 | 0.150 |
Why?
|
| Leiomyosarcoma | 1 | 2020 | 458 | 0.150 |
Why?
|
| Benzalkonium Compounds | 1 | 2015 | 24 | 0.140 |
Why?
|
| Asian Americans | 1 | 2020 | 674 | 0.140 |
Why?
|
| Peritoneal Neoplasms | 1 | 2021 | 626 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2017 | 386 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2021 | 814 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2012 | 3815 | 0.130 |
Why?
|
| Signal Transduction | 4 | 2012 | 23705 | 0.130 |
Why?
|
| Los Angeles | 1 | 2014 | 212 | 0.130 |
Why?
|
| Hirschsprung Disease | 1 | 2015 | 146 | 0.120 |
Why?
|
| Phosphatidylinositols | 1 | 1994 | 287 | 0.120 |
Why?
|
| Carbachol | 4 | 2005 | 229 | 0.120 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 4104 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2019 | 1338 | 0.120 |
Why?
|
| Bryostatins | 2 | 2003 | 24 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 1887 | 0.120 |
Why?
|
| Enteric Nervous System | 1 | 2015 | 163 | 0.120 |
Why?
|
| Cost Savings | 1 | 2018 | 917 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2012 | 5369 | 0.120 |
Why?
|
| Myosins | 1 | 1994 | 423 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3169 | 0.120 |
Why?
|
| Ablation Techniques | 1 | 2015 | 232 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2016 | 1769 | 0.110 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2012 | 195 | 0.110 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 830 | 0.110 |
Why?
|
| Macrolides | 2 | 2003 | 211 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15101 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 738 | 0.100 |
Why?
|
| Lymphoma | 1 | 2020 | 1883 | 0.100 |
Why?
|
| Chlorides | 2 | 2005 | 674 | 0.100 |
Why?
|
| Peritonitis | 1 | 2013 | 377 | 0.100 |
Why?
|
| Pertussis Toxin | 1 | 2011 | 181 | 0.100 |
Why?
|
| Humans | 25 | 2021 | 715594 | 0.100 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2014 | 373 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2020 | 4903 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 1994 | 945 | 0.100 |
Why?
|
| Quantum Dots | 1 | 2012 | 171 | 0.100 |
Why?
|
| Propionates | 1 | 2011 | 180 | 0.100 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2009 | 25 | 0.100 |
Why?
|
| Isoxazoles | 1 | 2011 | 217 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2012 | 19892 | 0.090 |
Why?
|
| Fibrosis | 1 | 2016 | 1916 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 937 | 0.090 |
Why?
|
| Hospitals, Community | 2 | 2021 | 334 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2004 | 8028 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 641 | 0.090 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 721 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1565 | 0.090 |
Why?
|
| Dinoprostone | 1 | 2011 | 598 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2528 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3050 | 0.080 |
Why?
|
| Emergencies | 1 | 2013 | 1123 | 0.080 |
Why?
|
| Organ Transplantation | 1 | 2017 | 1073 | 0.080 |
Why?
|
| Regeneration | 1 | 2016 | 1528 | 0.080 |
Why?
|
| Animals | 6 | 2023 | 169173 | 0.080 |
Why?
|
| Mice | 4 | 2023 | 80270 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 3991 | 0.070 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 11139 | 0.070 |
Why?
|
| Male | 11 | 2021 | 350143 | 0.070 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2005 | 103 | 0.070 |
Why?
|
| African Americans | 1 | 2020 | 4991 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2009 | 1850 | 0.070 |
Why?
|
| Adenocarcinoma | 3 | 2020 | 6320 | 0.070 |
Why?
|
| Female | 11 | 2021 | 377052 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 11192 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2132 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2326 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2016 | 2251 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3945 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2021 | 72448 | 0.060 |
Why?
|
| Muscarinic Agonists | 1 | 2003 | 88 | 0.060 |
Why?
|
| Protein Kinase C-delta | 1 | 2002 | 133 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9544 | 0.060 |
Why?
|
| Tritium | 1 | 2002 | 792 | 0.060 |
Why?
|
| Mannitol | 1 | 2002 | 185 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2286 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 257 | 0.050 |
Why?
|
| Survival Rate | 3 | 2021 | 13209 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 3569 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 619 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2021 | 7901 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 2932 | 0.050 |
Why?
|
| Protein Transport | 2 | 2005 | 2051 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 618 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1167 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13619 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2003 | 651 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2002 | 1028 | 0.040 |
Why?
|
| Middle Aged | 6 | 2020 | 214639 | 0.040 |
Why?
|
| United States | 3 | 2020 | 67895 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 2119 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2021 | 563 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 855 | 0.040 |
Why?
|
| Intestines | 1 | 2004 | 1918 | 0.030 |
Why?
|
| Lithium Chloride | 1 | 1994 | 88 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5407 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2020 | 1221 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2975 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2005 | 865 | 0.030 |
Why?
|
| Propensity Score | 1 | 2020 | 1759 | 0.030 |
Why?
|
| Injections | 1 | 2015 | 867 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3894 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2002 | 4149 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2555 | 0.020 |
Why?
|
| Rectum | 1 | 2015 | 883 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1994 | 1240 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8888 | 0.020 |
Why?
|
| Cattle | 1 | 1994 | 3952 | 0.020 |
Why?
|
| Trachea | 1 | 1994 | 1079 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2020 | 2495 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 12285 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5069 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10660 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12495 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2004 | 71 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 58293 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9838 | 0.020 |
Why?
|
| Incidence | 1 | 2021 | 20761 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18772 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 8897 | 0.010 |
Why?
|
| Aged | 3 | 2020 | 162392 | 0.010 |
Why?
|
| Calcium | 1 | 1994 | 5793 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 23385 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16726 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11238 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 28991 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 1134 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 9810 | 0.000 |
Why?
|
| Adult | 1 | 2014 | 212237 | 0.000 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_